" class="no-js "lang="en-US"> ZERO - Pharmtech Focus
Tuesday, January 31, 2023
ZERO | Pharmtech Focus

ZERO

About ZERO

ZERO

About

ZERO – The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action. We’re building Generation ZERO, the first generation of men free from prostate cancer, through our national run/walk series, education and patient support programs, and grassroots advocacy. ZERO is a 501(c)(3) philanthropic organization, accredited by the Better Business Bureau, with regional chapters across the country. We dedicate 85 cents of every dollar to research and programs.

Related Story

Novartis Pluvicto™ Approved by FDA as First Targeted Radioligand Therapy for Treatment of Progressive, PSMA-positive Metastatic Castration-resistant Prostate Cancer

March 24 2022

Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu […]